Evidence map›Paper›PMID 31400909›Full record

ArticleMayo Clinic proceedings2019

Model for End-Stage Liver Disease Score Predicts Development of First Episode of Spontaneous Bacterial Peritonitis in Patients With Cirrhosis.

Rashid Khan, Sujan Ravi, Sakkarin Chirapongsathorn, Whitney Jennings, Habeeb Salameh, Kirk Russ, Matt Skinner, Sandhya Mudumbi, Douglas Simonetto, Yong-Fang Kuo and 2 more

Abstract readMulticenter Study
In one paragraph

Article in Mayo Clinic proceedings, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Rashid KhanDivision of Gastroenterology and Hepatology, UTMB, Galveston, TX.
Sujan RaviDepartment of Internal Medicine, UAB, Birmingham, AL.
Sakkarin ChirapongsathornDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
Whitney JenningsDivision of Gastroenterology and Hepatology, University of Alabama at Birmingham, Birmingham, AL.
Habeeb SalamehDivision of Gastroenterology and Hepatology, UTMB, Galveston, TX.
Kirk RussDivision of Gastroenterology and Hepatology, University of Alabama at Birmingham, Birmingham, AL.
Matt SkinnerDepartment of Internal Medicine, UAB, Birmingham, AL.
Sandhya MudumbiDepartment of Internal Medicine, UAB, Birmingham, AL.
Douglas SimonettoDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
Yong-Fang KuoDepartment of Preventive Medicine and Biostatistics, UTMB, Galveston, TX.
Patrick S KamathDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
Ashwani K SingalDivision of Gastroenterology and Hepatology, University of Alabama at Birmingham, Birmingham, AL. Electronic address: ashwanisingal.com@gmail.com.

Funding

AHRQ HHS T32 HS013852
6 · The paper itself

Abstract

objectiveTo examine whether baseline model for end-stage liver disease (MELD) score in patients with cirrhosis and ascites predicts the future development of first spontaneous bacterial peritonitis (SBP) episode.

methodsA retrospective case-control study was performed at three academic centers to select patients admitted with first SBP episode (cases) and those with ascites admitted for decompensation without SBP (controls). Medical records from these centers were reviewed between January 1, 2008, and December 31, 2013. Cases and controls were matched (1:2) for age, sex, and race. Conditional logistic recession models were built to determine whether baseline MELD score (within a month before hospitalization) predicts first SBP episode.

resultsOf 697 patients (308, 230, and 159 from centers A, B, and C, respectively), cases and controls were matched in 94%, 89%, and 100% at three respective centers. In the pooled sample, probability of SBP was 11%, 31%, 71%, and 93% at baseline MELD scores less than or equal to 10, from 11 to 20, from 21 to 30, and greater than 30, respectively. Compared with MELD score less than or equal to 10, patients with MELD scores from 11 to 20, 21 to 30, and greater than 30 had six- (3- to 11-), 29- (12- to 69-), and 115- (22- to 598-) folds (95% CI) risk of SBP, respectively. Based on different MELD score cutoff points, MELD score greater than 17 was most accurate in predicting SBP occurrence. Analyzing 315 patients (152 cases) with available data on ascitic fluid protein level controlling for age, sex, and center, MELD score but not ascitic fluid protein associated with first SBP episode with respective odds ratios of 1.20 (1.14 to 1.26) and 0.88 (0.70 to 1.11).

conclusionBaseline MELD score predicts first SBP episode in patients with cirrhosis and ascites.

Indexed as

Hospital MortalityAcademic Medical CentersAgedAnti-Bacterial AgentsBacterial InfectionsCase-Control StudiesDisease ProgressionFemaleFollow-Up StudiesHumansLinear ModelsLiver CirrhosisLiver FailureMaleMiddle AgedPeritonitisAnti-Bacterial Agents

Identifiers

PMID31400909
PMCPMC9709904

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.